C12Y 304/21074
Venombin a
Official title: Venombin A (3.4.21.74)
C12Y304/21074 (Venombin a) appears on 3 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 9
- Assignees
- 10
- Inventors
- 29
- Latest grant
- 4 Jul 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 1 | 2 |
| 2022 | 0 | 3 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Snake venom thrombin-like enzyme marker peptide of Agkistrodon halys pallas and its application in the species identification of hemocoagulase for injection4 Jul 2023US 11,692,186 B2Avanc Pharmaceutical Co.,Ltd
- Recombinant batroxobin mixed composition and a hemostatic powder or hemostatic pad comprising same16 Feb 2021US 10,920,210 B2Nc Bit Inc.
- Recombinant fusion proteins for preventing or treating adhesions of tissues or organs17 Nov 2020US 10,837,007 B2Akesion GmbH
- Use of Tetramethylpyrazine Nitrone Derivatives In The Treatment of Ischemic Stroke4 Jun 2026US 2026/0151389 A1Guangzhou Magpie Pharmaceuticals Co., Ltd.
- Fibrinogen as adjuvant for antimicrobial agents and therapy11 Apr 2024US 2024/0115773 A1Fibriant B.V.
- Fibrin biopolymer formation and application device4 Aug 2022US 2022/0241152 A1Freedom, Inc.
- Device for fibrin-biopolymer-forming substance application4 Aug 2022US 2022/0241521 A1Freedom, Inc.
- Snake venom thrombin-like enzyme marker peptide of agkistrodon halys pallas and its application in the species identification of hemocoagulase for injection3 Feb 2022US 2022/0034853 A1Avanc Pharmaceutical Co.,Ltd
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.